Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)

$860,314RL1FY2007AGNIH

University Of California At Davis, Davis CA

Investigators

Paul J Hagermancontact

Linked publications & trials

Paper 30808398 Paper 26060190 Paper 25844075 Paper 25632275 Paper 25589822 Paper 25486200 Paper 25399540 Paper 25388402 Paper 24871547 Paper 24773414 Paper 24578183 Paper 24491663 Paper 24345444 Paper 24299169 Paper 23949830 Paper 23867198 Paper 23686745 Paper 23478018 Paper 23440729 Paper 23373759 Paper 23162607 Paper 23074671 Paper 23064752 Paper 23063447 Paper 23009394 Paper 23008705 Paper 22924671 Paper 22918986 Paper 22903889 Paper 22889812 Paper 22737597 Paper 22641815 Paper 22528549 Paper 22491193 Paper 22489017 Paper 22466801 Paper 22043169 Paper 22009360 Paper 22001913 Paper 21932336 Paper 21926154 Paper 21827901 Paper 21808616 Paper 21785977 Paper 21783174 Paper 21720454 Paper 21572337 Paper 21571002 Paper 21567456 Paper 21558427 Paper 21554789 Paper 21484870 Paper 21440572 Paper 21389081 Paper 21354978 Paper 21295394 Paper 21237174 Paper 21069606 Paper 20961665 Paper 20935171 Paper 20841969 Paper 20816038 Paper 20809278 Paper 20616364 Paper 20537351 Paper 20513237 Paper 20497189 Paper 20471964 Paper 20466021 Paper 20430935 Paper 20410144 Paper 20186122 Paper 20126296 Paper 20051238 Paper 20014363 Paper 19908235 Paper 19864489 Paper 19846466 Paper 19842197 Paper 19794313 Paper 19531693 Paper 19460937 Paper 19422761 Paper 19266053 Paper 19173699 Paper 19126569 Paper 19033593 Paper 18695063 Paper 18478592 Paper 18413472 Paper 18413371 Paper 18348275

View original record on NIH RePORTER →